W3C home > Mailing lists > Public > public-hcls-dse@w3.org > January to February 2007

dummy data

From: Dobson, Stephen <Stephen.Dobson@pfizer.com>
Date: Tue, 20 Feb 2007 13:23:56 -0500
Message-ID: <7A20EEC75BBEE542B9E40B92F58E8C5305A3AC10@groamrexm03.amer.pfizer.com>
To: <public-hcls-dse@w3.org>
Draft SDTM version of the Dummy Data is now uploaded to the DSE site
http://esw.w3.org/topic/HCLSIG/Drug_Safety_and_Efficacy

If you spot any errors let me know.  It should be straight forward to
correct.  I've included the meddra codes for preftext and SOC.  The SDTM
doesn't appear to include space for these codes, just the textual
description.

 

Cheers


Stephen.

 

________________________________

From: Dobson, Stephen 
Sent: Thursday, February 08, 2007 4:44 PM
To: public-hcls-dse@w3.org; 'eneumann@teranode.com'
Subject: RE: DSE TC Friday Jan 26

 

Hi All, 

 

I've added some dummy data to the resources section of DSE.  Adverse
events, vital signs, treatment and demog. 

I think it's internally consistent for the most part, though I'm sure
you could find errors (e.g. males having female AE's, serious adverse
events that are clearly only minor etc). 

 

I've created a fictional 300 subject 5 arm multi visit trial with 2 of
the arms as dose escalations.  

There are also multiple vital signs taken at each visit.  

It should be obvious what the columns refer to.  

Now I've written the code it should also be easy to mock up labs,
primary diagnosis, some sort of efficacy measure etc for these subjects.


 

I haven't had time to get into a CDISC format but will attempt to do so
at a later stage. 


Cheers

 

Stephen. 

 

 

________________________________

From: public-hcls-dse-request@w3.org
[mailto:public-hcls-dse-request@w3.org] On Behalf Of Eric Neumann
Sent: Thursday, January 25, 2007 4:23 PM
To: public-hcls-dse@w3.org
Subject: DSE TC Friday Jan 26

 

 

SW-HCLS(DSE)

Friday, 26 January, 8:30am-9:30am/13:30-14:30 UTC <http:// 

www.timeanddate.com/worldclock/personal.html? 

month=12&day=01&year=2006&hour=13&min=30&sec=0&p1=0>

  for a duration of 1 hour

Zakim Bridge +1.617.761.6200 <tel:+1.617.761.6200> , conference code  

3731 ("DSE1")

Coordinator: Eric Neumann <eneumann@teranode.com
<mailto:eneumann@teranode.com?Subject=Re%3A%20DSE%20TC%20Friday%20Jan%20
12&In-Reply-To=%253C74DD9C6C-9A33-419C-93E6-D3A5E1D51F2A%40teranode.com%
253E&References=%253C74DD9C6C-9A33-419C-93E6-D3A5E1D51F2A%40teranode.com
%253E> >

 

 

Agenda:

a) Attendance

b) Propose next DSE call Feb 9, 2007

c) Upcoming DIA CDM meeting, March 18, Florida

d) Discuss SDTM RDF example :
http://esw.w3.org/topic/HCLSIG/Drug_Safety_and_Efficacy/SDTM/Example_N3

e)    Possible Demo plans: Banff WWW2007, May ; DDT Boston (August?)--
what will it require?

 

cheers,

Eric

 






 

Eric Neumann, PhD

co-chair, W3C Healthcare and Life Sciences,

and Senior Director Product Strategy

Teranode Corporation

411 1st Avenue South, Suite 700

Seattle, WA 98104

+1 (781)856-9132

www.teranode.com 

 

 

----------------------------------------------------------------------
LEGAL NOTICE
Unless expressly stated otherwise, this message is confidential and may be privileged.  It is intended for the addressee(s) only.  Access to this E-mail by anyone else is unauthorized.  If you are not an addressee, any disclosure or copying of the contents of this E-mail or any action taken (or not taken) in reliance on it is unauthorized and may be unlawful.  If you are not an addressee, please inform the sender immediately.
Received on Tuesday, 20 February 2007 18:26:09 GMT

This archive was generated by hypermail 2.2.0+W3C-0.50 : Tuesday, 8 January 2008 14:11:53 GMT